Comparison between JFL Life Sciences IPO and Rhetan TMT IPO.
IPO Details
JFL Life Sciences IPO is a SME Fixed Price IPO proposed to list at NSE SME while Rhetan TMT IPO is a SME Fixed Price proposed to list at BSE SME.
Issue Size and Price
The total issue size of JFL Life Sciences IPO is up to ₹17.25 Cr whereas the issue size of the Rhetan TMT IPO is up to ₹53.09 Cr. The final issue price of JFL Life Sciences IPO is ₹61.00 per share and of Rhetan TMT IPO is ₹70.00 per share.
IPO Timetable
JFL Life Sciences IPO opens on Aug 25, 2022, while Rhetan TMT IPO opens on Aug 22, 2022. The closing date of JFL Life Sciences IPO and Rhetan TMT IPO is Aug 30, 2022, and Aug 25, 2022, respectively.
| | JFL Life Sciences IPO | Rhetan TMT IPO |
|---|
| Issue Open | Aug 25, 2022 | Aug 22, 2022 |
| Issue Close | Aug 30, 2022 | Aug 25, 2022 |
| Basis Of Allotment (Tentative) | Sep 05, 2022 | Aug 30, 2022 |
| Initiation of Refunds (Tentative) | Sep 06, 2022 | Sep 01, 2022 |
| Credit of Share (Tentative) | Sep 07, 2022 | Sep 02, 2022 |
| Listing date (Tentative) | Sep 08, 2022 | Sep 05, 2022 |
Financials & KPIs
JFL Life Sciences IPO P/E ratio is 26.52, as compared to Rhetan TMT IPO P/E ratio of 63.64.
Shares Offered
In the JFL Life Sciences IPO Retail Individual Investors (RII) are offered 14,14,000 shares while in Rhetan TMT IPO retail investors are offered 14,14,000 shares. Qualified Institutional Buyers (QIB) are offered in JFL Life Sciences IPO and in Rhetan TMT IPO.
| | JFL Life Sciences IPO | Rhetan TMT IPO |
|---|
| Market Maker Reservation | 1,50,000 shares | 4,16,000 shares |
| NII | 14,14,000 shares | 37,92,000 shares |
| RII | 14,14,000 shares | 37,92,000 shares |
| Total | 28,28,000 shares | 75,84,000 shares |
Bids Received (Subscription)
JFL Life Sciences IPO subscribed 8.93x in total, whereas Rhetan TMT IPO subscribed 1.47x.
